Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 184

1.

Hospital Utilization Among Rural Children Served by Pediatric Neurology Telemedicine Clinics.

Dayal P, Chang CH, Benko WS, Pollock BH, Crossen SS, Kissee J, Ulmer AM, Hoch JS, Warner L, Marcin JP.

JAMA Netw Open. 2019 Aug 2;2(8):e199364. doi: 10.1001/jamanetworkopen.2019.9364.

PMID:
31418803
2.

Inhalation Injury Does Not Influence The Amount of Blood Transfused to Major Burn Patients: A Secondary Analysis from The Transfusion Requirement in Burn Care Evaluation (TRIBE) Study.

Cartotto R, Taylor SL, Holmes JH, Arnoldo B, Peck M, Cochran A, Col BTK, Bhavsar D, Tredget EE, Stapelberg F, Friedman B, Mozingo D, Greenhalgh D, Pollock BH, Palmieri TL.

J Burn Care Res. 2019 Jul 17. pii: irz129. doi: 10.1093/jbcr/irz129. [Epub ahead of print]

PMID:
31314106
3.

Cardiopulmonary Testing Prior to Lung Resection: What are Thoracic Surgeons Doing?

Clark JM, Marrufo AS, Kozower BD, Tancredi DJ, Nuño M, Cooke DT, Pollock BH, Romano PS, Brown LM.

Ann Thorac Surg. 2019 Jun 7. pii: S0003-4975(19)30735-0. doi: 10.1016/j.athoracsur.2019.04.057. [Epub ahead of print]

PMID:
31181202
4.

Decreased Early Mortality in Young Adult Patients With Acute Lymphoblastic Leukemia Treated at Specialized Cancer Centers in California.

Alvarez EM, Malogolowkin M, Li Q, Brunson A, Pollock BH, Muffly L, Wun T, Keegan THM.

J Oncol Pract. 2019 Apr;15(4):e316-e327. doi: 10.1200/JOP.18.00264. Epub 2019 Mar 8.

PMID:
30849003
5.

Thoracic Surgeons' Beliefs and Practices on Smoking Cessation Before Lung Resection.

Marrufo AS, Kozower BD, Tancredi DJ, Nuño M, Cooke DT, Pollock BH, Romano PS, Brown LM.

Ann Thorac Surg. 2019 May;107(5):1494-1499. doi: 10.1016/j.athoracsur.2018.11.055. Epub 2018 Dec 23.

PMID:
30586576
6.

Restrictive Transfusion Strategy Is More Effective in Massive Burns: Results of the TRIBE Multicenter Prospective Randomized Trial.

Palmieri TL, Holmes JH, Arnoldo B, Peck M, Cochran A, King BT, Dominic W, Cartotto R, Bhavsar D, Tredget E, Stapelberg F, Mozingo D, Friedman B, Sen S, Taylor SL, Pollock BH.

Mil Med. 2019 Mar 1;184(Suppl 1):11-15. doi: 10.1093/milmed/usy279.

PMID:
30371811
7.

Increased clinical trial enrollment among adolescent and young adult cancer patients between 2006 and 2012-2013 in the United States.

Parsons HM, Penn DC, Li Q, Cress RD, Pollock BH, Malogolowkin MH, Wun T, Keegan THM.

Pediatr Blood Cancer. 2019 Jan;66(1):e27426. doi: 10.1002/pbc.27426. Epub 2018 Sep 6.

PMID:
30256525
8.

The Effects of Storage Age of Blood in Massively Transfused Burn Patients: A Secondary Analysis of the Randomized Transfusion Requirement in Burn Care Evaluation Study.

Cartotto R, Taylor SL, Holmes JH 4th, Peck M, Cochran A, King BT, Bhavsar D, Tredget EE, Mozingo D, Greenhalgh D, Pollock BH, Palmieri TL.

Crit Care Med. 2018 Dec;46(12):e1097-e1104. doi: 10.1097/CCM.0000000000003383.

PMID:
30234568
9.

Suppression of ribosomal protein RPS6KB1 by Nexrutine increases sensitivity of prostate tumors to radiation.

Hussain SS, Huang SB, Bedolla RG, Rivas P, Basler JW, Swanson GP, Hui-Ming Huang T, Narayanasamy G, Papanikolaou N, Miyamoto H, Yeh IT, Reddick RL, Pollock BH, Ghosh R, Kumar AP.

Cancer Lett. 2018 Oct 1;433:232-241. doi: 10.1016/j.canlet.2018.07.009. Epub 2018 Jul 9.

PMID:
30003927
10.

Prevention of cisplatin-induced hearing loss in children: Informing the design of future clinical trials.

Minasian LM, Frazier AL, Sung L, O'Mara A, Kelaghan J, Chang KW, Krailo M, Pollock BH, Reaman G, Freyer DR.

Cancer Med. 2018 May 30. doi: 10.1002/cam4.1563. [Epub ahead of print]

11.

Statistical competencies for medical research learners: What is fundamental?

Enders FT, Lindsell CJ, Welty LJ, Benn EKT, Perkins SM, Mayo MS, Rahbar MH, Kidwell KM, Thurston SW, Spratt H, Grambow SC, Larson J, Carter RE, Pollock BH, Oster RA.

J Clin Transl Sci. 2017 Jun;1(3):146-152. doi: 10.1017/cts.2016.31. Epub 2017 May 9.

12.

Transfusion Requirement in Burn Care Evaluation (TRIBE): A Multicenter Randomized Prospective Trial of Blood Transfusion in Major Burn Injury.

Palmieri TL, Holmes JH 4th, Arnoldo B, Peck M, Potenza B, Cochran A, King BT, Dominic W, Cartotto R, Bhavsar D, Kemalyan N, Tredget E, Stapelberg F, Mozingo D, Friedman B, Greenhalgh DG, Taylor SL, Pollock BH.

Ann Surg. 2017 Oct;266(4):595-602. doi: 10.1097/SLA.0000000000002408.

13.

Sociodemographic disparities in survival for adolescents and young adults with cancer differ by health insurance status.

DeRouen MC, Parsons HM, Kent EE, Pollock BH, Keegan THM.

Cancer Causes Control. 2017 Aug;28(8):841-851. doi: 10.1007/s10552-017-0914-y. Epub 2017 Jun 28.

14.

Medication prior authorization in pediatric hematology and oncology.

Dickens DS, Pollock BH.

Pediatr Blood Cancer. 2017 Jun;64(6). doi: 10.1002/pbc.26339. Epub 2016 Nov 5.

15.

Lifestyle and Clinical Correlates of Hepatocellular Carcinoma in South Texas: A Matched Case-control Study.

Ramirez AG, Muñoz E, Parma DL, Michalek JE, Holden AEC, Phillips TD, Pollock BH.

Clin Gastroenterol Hepatol. 2017 Aug;15(8):1311-1312. doi: 10.1016/j.cgh.2017.03.022. Epub 2017 Mar 23. No abstract available.

16.

Group-Wide, Prospective Study of Ototoxicity Assessment in Children Receiving Cisplatin Chemotherapy (ACCL05C1): A Report From the Children's Oncology Group.

Knight KR, Chen L, Freyer D, Aplenc R, Bancroft M, Bliss B, Dang H, Gillmeister B, Hendershot E, Kraemer DF, Lindenfeld L, Meza J, Neuwelt EA, Pollock BH, Sung L.

J Clin Oncol. 2017 Feb;35(4):440-445. doi: 10.1200/JCO.2016.69.2319. Epub 2016 Dec 12. Erratum in: J Clin Oncol. 2017 Apr 1;35(10):1141.

17.

Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trial.

Freyer DR, Chen L, Krailo MD, Knight K, Villaluna D, Bliss B, Pollock BH, Ramdas J, Lange B, Van Hoff D, VanSoelen ML, Wiernikowski J, Neuwelt EA, Sung L.

Lancet Oncol. 2017 Jan;18(1):63-74. doi: 10.1016/S1470-2045(16)30625-8. Epub 2016 Dec 1. Erratum in: Lancet Oncol. 2017 Jun;18(6):e301.

18.

Characteristics of Biostatistics, Epidemiology, and Research Design Programs in Institutions With Clinical and Translational Science Awards.

Rahbar MH, Dickerson AS, Ahn C, Carter RE, Hessabi M, Lindsell CJ, Nietert PJ, Oster RA, Pollock BH, Welty LJ.

Acad Med. 2017 Feb;92(2):229-236. doi: 10.1097/ACM.0000000000001350.

19.

Intervention trial with calcium montmorillonite clay in a south Texas population exposed to aflatoxin.

Pollock BH, Elmore S, Romoser A, Tang L, Kang MS, Xue K, Rodriguez M, Dierschke NA, Hayes HG, Hansen HA, Guerra F, Wang JS, Phillips T.

Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2016 Aug;33(8):1346-54. doi: 10.1080/19440049.2016.1198498. Epub 2016 Jul 28.

20.

Reaching high-risk underserved individuals for cancer genetic counseling by video-teleconferencing.

Mette LA, Saldívar AM, Poullard NE, Torres IC, Seth SG, Pollock BH, Tomlinson GE.

J Community Support Oncol. 2016 Apr;14(4):162-8. doi: 10.12788/jcso.0247.

21.

Low Enrollment of Adolescents and Young Adults Onto Cancer Trials: Insights From the Community Clinical Oncology Program.

Roth ME, O'Mara AM, Seibel NL, Dickens DS, Langevin AM, Pollock BH, Freyer DR.

J Oncol Pract. 2016 Apr;12(4):e388-95. doi: 10.1200/JOP.2015.009084. Epub 2016 Mar 29.

22.

Comparison of cancer survival trends in the United States of adolescents and young adults with those in children and older adults.

Keegan TH, Ries LA, Barr RD, Geiger AM, Dahlke DV, Pollock BH, Bleyer WA; National Cancer Institute Next Steps for Adolescent and Young Adult Oncology Epidemiology Working Group.

Cancer. 2016 Apr 1;122(7):1009-16. doi: 10.1002/cncr.29869. Epub 2016 Feb 5.

23.

Incidence and incidence trends of the most frequent cancers in adolescent and young adult Americans, including "nonmalignant/noninvasive" tumors.

Barr RD, Ries LA, Lewis DR, Harlan LC, Keegan TH, Pollock BH, Bleyer WA; US National Cancer Institute Science of Adolescent and Young Adult Oncology Epidemiology Working Group.

Cancer. 2016 Apr 1;122(7):1000-8. doi: 10.1002/cncr.29867. Epub 2016 Feb 5.

24.

p53-based strategy to reduce hematological toxicity of chemotherapy: A proof of principle study.

Ha CS, Michalek JE, Elledge R, Kelly KR, Ganapathy S, Su H, Jenkins CA, Argiris A, Swords R, Eng TY, Karnad A, Crownover RL, Swanson GP, Goros M, Pollock BH, Yuan ZM.

Mol Oncol. 2016 Jan;10(1):148-56. doi: 10.1016/j.molonc.2015.09.004. Epub 2015 Sep 18.

25.

How to Tell the Truth with Statistics: The Case for Accountable Data Analyses in Team-based Science.

Gelfond JA, Klugman CM, Welty LJ, Heitman E, Louden C, Pollock BH.

J Transl Med Epidemiol. 2014;2(2). pii: 1025.

26.

Comparative dosing and efficacy of sorafenib in hepatocellular cancer patients with varying liver dysfunction.

Al-Rajabi R, Patel S, Ketchum NS, Jaime NA, Lu TW, Pollock BH, Mahalingam D.

J Gastrointest Oncol. 2015 Jun;6(3):259-67. doi: 10.3978/j.issn.2078-6891.2015.005.

27.

Evaluating Academic Scientists Collaborating in Team-Based Research: A Proposed Framework.

Mazumdar M, Messinger S, Finkelstein DM, Goldberg JD, Lindsell CJ, Morton SC, Pollock BH, Rahbar MH, Welty LJ, Parker RA; Biostatistics, Epidemiology, and Research Design (BERD) Key Function Committee of the Clinical and Translational Science Awards (CTSA) Consortium.

Acad Med. 2015 Oct;90(10):1302-8. doi: 10.1097/ACM.0000000000000759.

28.

Assessing statistical competencies in clinical and translational science education: one size does not fit all.

Oster RA, Lindsell CJ, Welty LJ, Mazumdar M, Thurston SW, Rahbar MH, Carter RE, Pollock BH, Cucchiara AJ, Kopras EJ, Jovanovic BD, Enders FT.

Clin Transl Sci. 2015 Feb;8(1):32-42. doi: 10.1111/cts.12204. Epub 2014 Sep 12.

29.

The Development of a Minority Recruitment Plan for Cancer Clinical Trials.

Trevino M, Padalecki S, Karnad A, Parra A, Weitman S, Nashawati M, Pollock BH, Ramirez A, Thompson IM.

J Community Med Health Educ. 2013 Sep 1;3(5):1000230.

30.

Promoting Factors and Barriers to Participation in Early Phase Clinical Trials: Patients Perspectives.

Chalela P, Suarez L, Muñoz E, Gallion KJ, Pollock BH, Weitman SD, Karnad A, Ramirez AG.

J Community Med Health Educ. 2014 Apr 24;4(281):1000281.

31.

Should we move beyond VEGF inhibition in metastatic colorectal cancer? Lessons from early phase clinical trials.

Patel SR, Karnad AB, Ketchum NS, Pollock BH, Sarantopoulos J, Weitman S, Mahalingam D.

J Gastrointest Oncol. 2014 Apr;5(2):99-103. doi: 10.3978/j.issn.2078-6891.2014.002.

32.

The Ontology of Clinical Research (OCRe): an informatics foundation for the science of clinical research.

Sim I, Tu SW, Carini S, Lehmann HP, Pollock BH, Peleg M, Wittkowski KM.

J Biomed Inform. 2014 Dec;52:78-91. doi: 10.1016/j.jbi.2013.11.002. Epub 2013 Nov 13.

33.

Early Phase Clinical Trials: Referral Barriers and Promoters among Physicians.

Ramirez AG, Chalela P, Suarez L, Muñoz E, Pollock BH, Weitman SD, Gallion KJ.

J Community Med Health Educ. 2012 Sep 24;2(8). pii: 1000173.

34.

The mountain cedar model in clinical trials of seasonal allergic rhinoconjunctivitis.

Andrews CP, Ratner PH, Ehler BR, Brooks EG, Pollock BH, Ramirez DA, Jacobs RL.

Ann Allergy Asthma Immunol. 2013 Jul;111(1):9-13. doi: 10.1016/j.anai.2013.05.004. Epub 2013 May 31.

PMID:
23806453
35.

Strategies for developing biostatistics resources in an academic health center.

Welty LJ, Carter RE, Finkelstein DM, Harrell FE Jr, Lindsell CJ, Macaluso M, Mazumdar M, Nietert PJ, Oster RA, Pollock BH, Roberson PK, Ware JH; Biostatistics, Epidemiology, and Research Design Key Function Committee of the Clinical and Translational Science Award Consortium.

Acad Med. 2013 Apr;88(4):454-60. doi: 10.1097/ACM.0b013e31828578ed.

36.

Ontology-based federated data access to human studies information.

Sim I, Carini S, Tu SW, Detwiler LT, Brinkley J, Mollah SA, Burke K, Lehmann HP, Chakraborty S, Wittkowski KM, Pollock BH, Johnson TM, Huser V; Human Studies Database Project.

AMIA Annu Symp Proc. 2012;2012:856-65. Epub 2012 Nov 3.

37.

Extremely low-frequency magnetic fields and survival from childhood acute lymphoblastic leukemia: an international follow-up study.

Schüz J, Grell K, Kinsey S, Linet MS, Link MP, Mezei G, Pollock BH, Roman E, Zhang Y, McBride ML, Johansen C, Spix C, Hagihara J, Saito AM, Simpson J, Robison LL, Dockerty JD, Feychting M, Kheifets L, Frederiksen K.

Blood Cancer J. 2012 Dec 21;2:e98. doi: 10.1038/bcj.2012.43.

38.

Power, Ethics and Obligation.

Gelfond JA, Heitman E, Pollock BH, Klugman CH.

Stat Med. 2012 Dec 20;31(29):4140-4141. doi: 10.1002/sim.5578. Epub 2012 Nov 23. No abstract available.

39.

Chemotherapy for initial induction failures in childhood acute lymphoblastic leukemia: a Children's Oncology Group Study (POG 8764).

Joyce MJ, Pollock BH, Devidas M, Buchanan GR, Camitta B.

J Pediatr Hematol Oncol. 2013 Jan;35(1):32-5. doi: 10.1097/MPH.0b013e318279afdd.

40.

Difficult encounters with psychiatric patients: a South Texas Psychiatry practice-based research network (PBRN) study.

Sellers RV, Salazar R, Martinez C Jr, Gelfond SD, Deuter M, Hayes HG, Ketchum N, Pollock BH.

J Am Board Fam Med. 2012 Sep-Oct;25(5):669-75. doi: 10.3122/jabfm.2012.05.120050.

41.

Toxic epidermal necrolysis: five years of treatment experience from a burn unit.

Firoz BF, Henning JS, Zarzabal LA, Pollock BH.

J Am Acad Dermatol. 2012 Oct;67(4):630-5. doi: 10.1016/j.jaad.2011.12.014. Epub 2012 Jan 27. Erratum in: J Am Acad Dermatol. 2013 Dec;69(6):1048.

PMID:
22285617
42.

A comparison of races and leukemia subtypes among patients in different cancer survivorship phases.

Pandya DM, Patel S, Ketchum NS, Pollock BH, Padmanabhan S.

Clin Lymphoma Myeloma Leuk. 2011 Jun;11 Suppl 1:S114-8. doi: 10.1016/j.clml.2011.05.036.

PMID:
22035740
43.
44.

Prevalence, severity, and treatment of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) skin and soft tissue infections in 10 medical clinics in Texas: a South Texas Ambulatory Research Network (STARNet) study.

Forcade NA, Parchman ML, Jorgensen JH, Du LC, Nyren NR, Treviño LB, Peña J, Mann MW, Muñoz A, Treviño SB, Mortensen EM, Wickes BL, Pollock BH, Frei CR.

J Am Board Fam Med. 2011 Sep-Oct;24(5):543-50. doi: 10.3122/jabfm.2011.05.110073.

45.

Principles for the ethical analysis of clinical and translational research.

Gelfond JA, Heitman E, Pollock BH, Klugman CM.

Stat Med. 2011 Oct 15;30(23):2785-92. doi: 10.1002/sim.4282. Epub 2011 Jul 12.

46.

Candidate gene association analysis of acute lymphoblastic leukemia identifies new susceptibility locus at 11p15 (LMO1).

Beuten J, Gelfond JA, Piwkham D, Pollock BH, Winick NJ, Collier AB 3rd, Tomlinson GE.

Carcinogenesis. 2011 Sep;32(9):1349-53. doi: 10.1093/carcin/bgr091. Epub 2011 May 21.

PMID:
21602560
47.

Polymorphisms in CYP1A1 and ethnic-specific susceptibility to acute lymphoblastic leukemia in children.

Swinney RM, Beuten J, Collier AB 3rd, Chen TT, Winick NJ, Pollock BH, Tomlinson GE.

Cancer Epidemiol Biomarkers Prev. 2011 Jul;20(7):1537-42. doi: 10.1158/1055-9965.EPI-10-1265. Epub 2011 May 17.

48.

Trends and co-trends of prostate-specific antigen and body mass index in a screened population.

Ankerst DP, Pollock BH, Liang Y, Dizdarevic N, Kyrylenko S, Boeck A, Thompson IM, Leach R.

Urology. 2011 Jul;78(1):10-6. doi: 10.1016/j.urology.2011.01.069. Epub 2011 May 7.

49.

Multilocus association of genetic variants in MLL, CREBBP, EP300, and TOP2A with childhood acute lymphoblastic leukemia in Hispanics from Texas.

Piwkham D, Gelfond JA, Rerkamnuaychoke B, Pakakasama S, Rebel VI, Pollock BH, Winick NJ, Collier AB 3rd, Tomlinson GE, Beuten J.

Cancer Epidemiol Biomarkers Prev. 2011 Jun;20(6):1204-12. doi: 10.1158/1055-9965.EPI-11-0059. Epub 2011 Apr 14.

50.

The human studies database project: federating human studies design data using the ontology of clinical research.

Sim I, Carini S, Tu S, Wynden R, Pollock BH, Mollah SA, Gabriel D, Hagler HK, Scheuermann RH, Lehmann HP, Wittkowski KM, Nahm M, Bakken S.

Summit Transl Bioinform. 2010 Mar 1;2010:51-5.

Supplemental Content

Loading ...
Support Center